Log in to your Inderes Free account to see all free content on this page.
OptiCept Technologies
2.80 SEK
-12.09 %
Less than 1K followers
OPTI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-12.09 %
-26.32 %
-44.22 %
-31.71 %
-43.55 %
-42.68 %
-78.09 %
-92.55 %
-44.47 %
OptiCept Technologies provides the food and plant industry with technological solutions that are used to increase the sustainability of various raw materials. The company works with biological processes that provide increased extraction from the raw material, reduced waste and maintained taste, aroma, color, nutritional content. The company has a patented technology within PEF (pulsed electric field) and VI (Vacuum Infusion). The company sells its products on a global level. The headquarters are located in Lund.
Read moreMarket cap
182.41M SEK
Turnover
1.18M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
18.12.
2025
Extraordinary general meeting '25
27.2.
2026
Annual report '25
21.5.
2026
General meeting '26
All
Research
Press releases
3rd party
ShowingAll content types
Correction: OptiCept Technologies Interim Report Q3 2025
Strong quarter and new financing show the path to positive EBITDA for the full year 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio